Contrary to existing antimicrobial coatings, which function by eliminating microorganisms upon contact over some adequate duration of time, the technology developed by FendX takes a preventative approach. Utilizing nanotechnology to develop film and spray protective coatings that prevent microbial adherence to surfaces, thereby minimizing the potential for transmission. This is a significant departure from reactive coating surfaces in the market, offering a proactive method for reducing the occurrence and spread of HAIs.
REPELWRAP™ film, is FendX’s lead product in development and is with their manufacturer who is gearing up to conduct pilot runs on their commercial manufacturing line to create intermediate films for testing. FendX is also developing a spray-based product using their patent-pending nanotechnology. This spray offers the same preventative measures against microbial adherence and has the potential to be more versatile and easier-to-apply to surfaces. It not only demonstrates the same repelling properties but also effectively inactivates any residual microorganisms on the coated surface.
FendX is focused on healthcare settings, but is also exploring potential applications in other multiple billion high-traffic industries. It is anticipated that FendX’s future protective coatings can be applied to various high-touch surfaces: from bed rails and IV poles in healthcare to potential handrails in public transport systems to door handles in restaurants and public bathrooms. Given that the technology inhibits microbial adherence, it has the potential to significantly reduce the spread of pathogens in virtually any setting where human interaction with surfaces occurs. This broad applicability signifies that the market opportunity could be vastly larger than the projected $7.6 billion for antimicrobial coatings by 2025, opening doors to various industries and settings.
Leave a reply